Antigen Presenting System News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Antigen presenting system. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Antigen Presenting System Today - Breaking & Trending Today

GSK completes acquisition of Affinivax, Inc.

GSK plc (LSE/NYSE: GSK) today announced it has completed the acquisition of Affinivax, Inc (Affinivax), a clinical-stage biopharmaceutical company based in Cambridge (Boston, Massachusetts). Affinivax has pioneered the development of a novel class of vaccines, the most advanced of which are next-generation pneumococcal vaccines. ....

United States , United Kingdom , Tony Wood , Affinivax Inc , Drug Administration , Multiple Antigen Presenting System , Chief Scientific Officer , Breakthrough Therapy , Anti Trust Improvements Act , Antigen Presenting System , Infectious Diseases , Medical Specialties , Merger And Acquisition , Pneumococcal Conjugate Vaccine , Pneumococcal Infection , Pneumococcal Polysaccharide Vaccine , Pneumococcal Vaccine , Streptococcus Pneumoniae ,

GSK completes acquisition of Affinivax

GSK completes acquisition of Affinivax ....

United States , United Kingdom , Tony Wood , Drug Administration , Affinivax Inc , Multiple Antigen Presenting System , Breakthrough Therapy , Anti Trust Improvements Act , Antigen Presenting System , Chief Scientific Officer ,

GSK completes acquisition of Affinivax, Inc.

GSK plc (LSE/NYSE: GSK) today announced it has completed the acquisition of Affinivax, Inc (Affinivax), a clinical-stage biopharmaceutical company based in Cambridge (Boston, Massachusetts). Affinivax has pioneered the development of a novel class of vaccines, the most advanced of which are next-generation . ....

United States , United Kingdom , Tony Wood , Company Annual Report On Form , Us Centers For Disease , Drug Administration , Affinivax Inc , Multiple Antigen Presenting System , Chief Scientific Officer , Breakthrough Therapy , Anti Trust Improvements Act , Antigen Presenting System , Annual Report , Disease Control ,

GSK to acquire clinical-stage biopharmaceutical company Affinivax, Inc.

GSK plc (LSE/NYSE: GSK) today announced that it has entered into a definitive agreement to acquire Affinivax, Inc. (Affinivax), a clinical-stage biopharmaceutical company based in Cambridge, Boston, Massachusetts, for a $2.1 billion upfront payment and up to $1.2 billion in potential development milestones . ....

United States , United Kingdom , Steven Brugger , Hal Barron , Drug Administration , Constant Exchange Rate , Affinivax Inc , Multiple Antigen Presenting System , Chief Scientific Officer , Breakthrough Therapy , Boston Children , Anti Trust Improvements Act , Compound Annual Growth Rate , Constant Exchange , Antigen Presenting System ,

GSK to acquire clinical-stage biopharmaceutical company Affinivax

GSK to acquire clinical-stage biopharmaceutical company Affinivax ....

United States , United Kingdom , Steven Brugger , Hal Barron , Drug Administration , Constant Exchange Rate , Affinivax Inc , Multiple Antigen Presenting System , Anti Trust Improvements Act , Compound Annual Growth Rate , Constant Exchange , Antigen Presenting System , Chief Scientific Officer , Breakthrough Therapy , Boston Children ,